Number,

Medicine, 

Longevity.

We build precise AI disease models to make high-accuracy predictions of clinical trial outcomes for all diseases.

Sign up now to receive our performance update!

Demiurge has achieved 85.2% (104/122) accuracy in our prospective predictions of phase 2 and phase 3 clinical trial results in 2020/2021.

85.2%

PREDICTION ACCURACY RATE

as of 15 May 2021 
for all therapeutic areas excluding genetic disorders and hematological disorders. 

All%20Validated%20Prediction%20Performan

88.6%

PREDICTION ACCURACY RATE

Even for new diseases like COVID-19 without any preexisting clinical data, Demiurge published a detailed COVID-19 disease model in March 2020 (Lovetrue, 2020 here) and has achieved 88.6% accuracy (31/35) in prospective predictions of phase 2 and phase 3 COVID-19 clinical trial results in 2020/2021.

as of 15 May 2021

COVID-19%20Validated%20Prediction%20Perf

+40.2%

Demiurge's prediction accuracy has beaten the weighted benchmark by a wide margin of +40.2%.   

as of 15 May 2021

Demiurge
Weighted
Benchmark
45%
85.2%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Prediction Accuracy

INDICATIONS

131

26

THERAPEUTIC ARES

Demiurge has made 280+ prospective predictions in public covering 131 indications in 26 therapeutic areas. 

as of 15 May 2021

3_edited.png
logo front page.png